Abnormal expression of E-cad was observed in 29 out of 33 GC cases (87.9%); the remaining four cases (one diffuse type and three intestinal-type carcinomas) displayed normal membranous expression of E-cad (12.1%). This evidence concerns the gene CDH1 and carcinoma.